Literature DB >> 2535986

Effect of human semen on herpes-simplex virus-2.

J K Sherman1, P N Morgan.   

Abstract

This study was designed to evaluate the suggestion of inhibition of infectivity of HSV-2 by seminal fluid by examining relationships between HSV-2 and components of human semen. Viral infectivity was quantitated by TCID50 measurements of CPE in comparing viral inoculated aliquots of whole semen, seminal fluid, and control (EMEM) medium during incubation at 0, 5, and 24 hours. Statistical analysis of data from 15 experiments revealed inhibition by seminal fluid during 5 hours of incubation. After 24 hours viral infectivity was maintained significantly higher with whole semen than with other treatments, suggesting favorable spermatozoal interaction. Electron microscopy revealed no intimate ultrastructural relationship between the virion and the spermatozoon.

Entities:  

Mesh:

Year:  1989        PMID: 2535986     DOI: 10.1016/s0015-0282(16)60454-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Determination of the proteins and capsids of herpes simplex virus in human spermatozoa.

Authors:  E N Bocharova; R A Abdumalikov; E E Bragina; R R Klimova; S M Adueva; M G Medzhidova; L F Kurilo; A A Kushch
Journal:  Dokl Biol Sci       Date:  2003 Jul-Aug

2.  Seminal vesicle fluid increases the efficacy of intravaginal HSV-2 vaccination.

Authors:  A Varese; F Remes Lenicov; M Gonzalez Prinz; A Paletta; G Ernst; C Maeto; A Merlotti; J Sabatte; S Símula; M P Holgado; E Dantas; J Geffner; A Ceballos
Journal:  Mucosal Immunol       Date:  2017-07-26       Impact factor: 7.313

Review 3.  Viruses in the mammalian male genital tract and their effects on the reproductive system.

Authors:  N Dejucq; B Jégou
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

Review 4.  Infection and pyospermia in male infertility.

Authors:  N Bar-Chama; H Fisch
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.